Saturday Rounds: Week of October 31–November 6, 2026

Long-term safety catches up with the platforms. Weekly Biotech Signal Review · Completed reporting week: October 31–November 6, 2026 · Published November 7, 2026 Report at a glance: Novartis confirmed nine tumor cases after Zolgensma, a Nature Genetics paper tied CAR-T to clonal expansion in…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *